Status
Conditions
About
The goal of this study is to observe metabolic features associated with human melanoma tumors.
Full description
This is a single center, correlative study designed to assess metabolic features of melanoma tumors in patients. The study will involve the collection of melanoma tissue at the time of surgical biopsy or excision. All samples will be assessed by mass spectrometry for metabolomic analysis. A subset of patients will have received [U-13C]glucose infusions which will be utilized for isotope tracing metabolic analysis. Relevant clinical data (eg survival, metastasis) will be correlated with metabolic findings.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
400 participants in 2 patient groups
Loading...
Central trial contact
Aleuna Lee
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal